NEW YORK (GenomeWeb News) – Hologic this week announced a handful of executive appointments and the impending retirement of its CFO.
The firm said that it has named Eric Compton to the newly-established position of chief operating officer. He will be responsible for overseeing all of the firm's commercial operations in the US, and its global research and development, manufacturing, and service operations. Compton most recently served as worldwide president of Johnson & Johnson's Ortho Clinical Diagnostics business.
Hologic also named Claus Egstrand its new senior VP and general manager, international. He will be responsible for the company's operations outside of the US. Egstrand previously held senior positions at Merck, Stryker, Pfizer Consumer Healthcare, and Pharmacia.
In addition, David Harding, who previously served as Hologic's group senior VP and GM of women's health, has been named senior VP of corporate strategy.
CFO Glenn Muir, who began serving in that post in 1992, will retire from the firm at the end of November. Hologic said that it will immediately begin the search for a new CFO.
SISCAPA Assay Technologies has named Selena Larkin its vice president of marketing and sales. Larkin joins the mass spec assay firm after recently serving as global director of pharmaceutical strategy at Agilent Technologies. She previously held positions at Applied Biosystems/Sciex and Irvine Scientific.
BioNano Genomics has appointed Joel Jung as chief financial officer. He formerly was CFO and treasurer for Celera and most recently he was CFO of Agraquest.
CombiMatrix has hired pediatric pathologist Weslie Tyson as its new chief medical officer, replacing Richard Hockett. Tyson will take up his new post on April 8 and report to CEO Mark McDonough.
Tyson, a pediatric and perinatal pathologist for more than two decades, comes to CombiMatrix from UniPath, a pathology group that serves several hospitals and labs. There, he founded the pediatric/neonatology section and was in charge of pediatric and perinatal services since 1999.
Champions Oncology has hired Ido Ben-Zvi to serve as its director of bioinformatics and machine learning.
He will be responsible for using the data in the company's TumorBank to support its Translational Oncology solutions that are offered to pharmaceutical companies. Prior to joining Champions Oncology, Ben-Zvi was a visiting researcher with Microsoft Research. Before that, he held multiple positions with Frontline PCB Solutions in software engineering, algorithm development, and data mining. He has also worked on software and algorithm development at Celltrex, Zapper, and Technomatix.
Saskia Biskup, cofounder and managing director of CeGaT, has won the European Commission's 2014 EU Prize for Women Innovators. Biskup co-founded the genetic diagnostics company CeGaT in 2009. It offers a range of tests, including next-gen sequencing-based panels for inherited disorders.
Islet Sciences, a Raleigh, NC-based developer of therapeutics and molecular diagnostics for diabetes and metabolic disorders, said this week that it has appointed Michael Luther to its board of directors. Luther is senior VP of discovery and development at Albany Molecular Research.
Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.